What Can We Learn from COVID-19 Drug Development and Access for Non-Pandemic Diseases? A Chinese Perspective

American Journal of Bioethics 21 (12):42-45 (2021)
  Copy   BIBTEX

Abstract

The target article by Lynch et al. offers approaches for improving trial availability and Expanded Access for non-pandemic diseases based on the analysis of the COVID-19 experience in the US...

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Please, Don’t Fly Me to the Moon.Jason Karlawish - 2021 - American Journal of Bioethics 21 (12):20-22.
Solidarity in the Time of COVID-19?Floris Tomasini - 2021 - Cambridge Quarterly of Healthcare Ethics 30 (2):234-247.
COVID-19 Pandemic: The Circus is Over, for the Moment.Philip Morrissey - 2020 - Journal of Bioethical Inquiry 17 (4):591-593.
Real life stories when one has a disability in the time of COVID-19.Julie Phillips & Rea Kirk - 2020 - Research and Humanities in Medical Education 7:209-213.
Politicizing COVID-19 Vaccines in the Press: A Critical Discourse Analysis.Ali Haif Abbas - 2022 - International Journal for the Semiotics of Law - Revue Internationale de Sémiotique Juridique 35 (3):1167-1185.

Analytics

Added to PP
2021-11-22

Downloads
7 (#1,360,984)

6 months
6 (#512,819)

Historical graph of downloads
How can I increase my downloads?